Kura Oncology reports preclinical data on ziftomenib
PremiumThe FlyKura Oncology reports preclinical data on ziftomenib
17d ago
Kura Oncology initiated with a Buy at UBS
Premium
The Fly
Kura Oncology initiated with a Buy at UBS
17d ago
Kura Oncology presents new data on KO-2806 with targeted therapies
Premium
The Fly
Kura Oncology presents new data on KO-2806 with targeted therapies
18d ago
Kura Oncology appoints Vasconcelles to board of directors
PremiumThe FlyKura Oncology appoints Vasconcelles to board of directors
2M ago
Kura Oncology reports Q2 EPS (59c), consensus (63c)
Premium
The Fly
Kura Oncology reports Q2 EPS (59c), consensus (63c)
3M ago
Kura Oncology announces FDA clearance of IND application for ziftomenib
Premium
The Fly
Kura Oncology announces FDA clearance of IND application for ziftomenib
3M ago
Kura Oncology Enhances Equity Plan and Elects Directors
PremiumCompany AnnouncementsKura Oncology Enhances Equity Plan and Elects Directors
5M ago
Kura Oncology reports inducement grants under Nasdaq listing rule
Premium
The Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
5M ago
Investor Enthusiasm Soars for Kura Oncology (NASDAQ:KURA)
Premium
Market News
Investor Enthusiasm Soars for Kura Oncology (NASDAQ:KURA)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100